Chronic Heart Failure (CHF) Clinical Trial
Official title:
A Prospective Evaluation of Natriuretic Peptide Based Referral of CHF Patients in Primary Care
This low interventional study, whose unique intervention was to measure the blood level of a biomarker called NT-proBNP in chronic heart failure patients daily followed-up by Primary Care Physicians (PCPs) in Europe, assessed if the cardiologist referral guided by NT-proBNP measurement in patients who were currently judged by PCPs as being stable, would lead to optimization of HF treatment, defined in adherence to treatment recommendations of the current European Society of Cardiology guidelines for the treatment of heart failure.
In the majority of European countries, the primary management of chronic heart failure patients was performed by General Practitioners in collaboration with cardiologists (specialists). Previous studies had shown that many patients suffering from CHF do not receive optimal pharmacological and/or device treatment for their disease. An increase in natriuretic peptides (BNP, NT-proBNP) was associated with increased risk of cardiovascular events in heart failure patients. The purpose of the present study was to assess if a referral of clinical stable chronic heart failure patients with reduced ventricular ejection fraction (EF < or = 40%) and NT-proBNP level > or = 600 pg/mL to a specialist (cardiologist) led to treatment optimization, defined as adherence to the treatment recommendations according to the European Society of Cardiology (ESC) guidelines. In addition, data obtained in this study was used to describe demographic, clinical (including NT-proBNP levels) and treatment characteristics of CHF patients who were managed in the primary care setting across Europe.. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT02892747 -
Dietetics Education Focused on Malnutrition Prevention
|
N/A | |
| Completed |
NCT01581008 -
Improving Symptoms and Quality of Life in Chronic Heart Failure: Pilot Study
|
N/A | |
| Recruiting |
NCT06248658 -
Assessment of the Impact of Clinical Decision Support Systems Included in Electronic Health Records
|
||
| Completed |
NCT02884206 -
Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction
|
Phase 3 | |
| Enrolling by invitation |
NCT04790214 -
Effect of a Cardiac Rehabilitation Program on Chronic Heart Failure Patients in Yaoundé, Cameroon
|
N/A | |
| Active, not recruiting |
NCT04041193 -
An Innovative Disease-net Management Model for Non-communicable Diseases (SIDERA^B)
|
N/A | |
| Completed |
NCT01546532 -
Renal Hemodynamic Effects of RLX030A in Subjects With Chronic Heart Failure (CHF)
|
Phase 2 | |
| Completed |
NCT01197313 -
Depression and Quality of Life in Chronic Heart Failure Patients and the Caregivers
|
N/A | |
| Completed |
NCT04225728 -
Evaluation on Performance and Oxydative Stress in Patient With Iron deficIency and Stable Heart Failure Study
|
Phase 4 |